Driving reinvestment in R&D for antibiotics and advocating their responsible use

WP3A: Project management and governance

Academic: Stephan Harbarth, University of Geneva, Switzerland
EFPIA: Judy Hackett, Astra Zeneca AB

E. Bettiol, S. Legros, F. Jantarada (University of Geneva)

The private partners in DRIVE-AB are: AstraZeneca AB, GlaxoSmithKline Research & Development, F. Hoffmann-La Roche Ltd, MSD, Astellas Pharma Europe LTD, Pfizer Limited and Sanofi-Aventis Research & Development


  1. Establish governance structure for the DRIVE-AB network.
  2. Coordinate the work packages and their collaboration, supporting the implementation of any changes in activities or the network.
  3. Ensure and assist in day-to-day operational management, providing administrative and logistic support to the work packages and Steering Committee.
  4. Ensure adherence to the project agreement, monitoring the effective execution of tasks and timely achievement of project deliverables and milestones.
  5. Provide financial management of the network, with oversight of resource usage and payment.
  6. Protect and monitor intellectual property.


For more detail about Package 3A progress, please see our past NEWSLETTERS.


Article: Antibiotic research and development: business as usual?